Since its market introduction in 2000, TiUnite has shown that it serves to maintain implant stability immediately after placement with enhanced osseointegration and anchorage in surrounding bone.
Maintaining marginal bone in the long term is crucial for maximizing functional endurance and ensuring esthetics with long-term soft tissue support.
As you would expect from Nobel Biocare, TiUnite supports stable marginal bone levels after the initial bone remodeling phase and over the long term.
TiUnite expands treatment possibilities while providing safe and reliable outcomes. Implants with the TiUnite surface can be used in all indications, bone types and treatment protocols. The longest clinical data available for TiUnite implants, immediately loaded in regions of predominantly soft bone, demonstrates a 97.9% cumulative survival rate (CSR) and stable marginal bone levels, ten years after implant placement.
Results of clinical use demonstrate that dental professionals can effectively reduce the time at risk for immediately loaded implants using TiUnite.
More than just a well-known brand, TiUnite has set the standard in implant surface technology for more than a decade. To date, it has been clinically documented in more than 190 publications with over 9,600 patients, 29,000 implants and—in some studies—more than 10 years of follow-up. In total, more than 11 million implants with TiUnite have been used.